Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C

Clinical trial NCT06082336 · RECRUITING

Trial details

NCT number: NCT06082336
Sponsor: MagIA Diagnostics
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Combined Point of Care Diagnostic of HIV, HBV and HCV

Start date: 2024-09-16
Primary completion: 2025-08-26
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.